BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37659675)

  • 21. Barrett's esophagus.
    Spechler SJ
    Semin Gastrointest Dis; 1996 Apr; 7(2):51-60. PubMed ID: 8705259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma.
    Cotton CC; Eluri S; Shaheen NJ
    Gastroenterol Clin North Am; 2022 Sep; 51(3):485-500. PubMed ID: 36153106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for Barrett's esophagus.
    Zakko L; Lutzke L; Wang KK
    Minerva Med; 2017 Feb; 108(1):28-42. PubMed ID: 27792223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The spectrum of columnar-lined esophagus--Barrett's esophagus.
    Tytgat GN; Hameeteman W; Onstenk R; Schotborg R
    Endoscopy; 1989 Jul; 21(4):177-85. PubMed ID: 2673752
    [No Abstract]   [Full Text] [Related]  

  • 25. Beyond Dysplasia Grade: The Role of Biomarkers in Stratifying Risk.
    Dunbar KB; Souza RF
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):447-459. PubMed ID: 28577766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus.
    Hennig EE; Mikula M; Orlowska J; Jarosz D; Bielasik A; Regula J; Ostrowski J
    J Mol Med (Berl); 2008 Feb; 86(2):233-42. PubMed ID: 17952395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening and surveillance for Barrett's esophagus: current issues and future directions.
    Choi SE; Hur C
    Curr Opin Gastroenterol; 2012 Jul; 28(4):377-81. PubMed ID: 22508325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis.
    Ong CA; Lao-Sirieix P; Fitzgerald RC
    World J Gastroenterol; 2010 Dec; 16(45):5669-81. PubMed ID: 21128316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett's esophagus patients after extended follow up; results from Dutch surveillance cohorts.
    Hoefnagel SJM; Mostafavi N; Timmer MR; Lau CT; Meijer SL; Wang KK; Krishnadath KK
    PLoS One; 2020; 15(4):e0231419. PubMed ID: 32282835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barrett's esophagus.
    Rastogi A; Sharma P
    Endoscopy; 2005 Nov; 37(11):1105-10. PubMed ID: 16281140
    [No Abstract]   [Full Text] [Related]  

  • 31. Barrett's esophagus and Barrett's-related dysplasia.
    Goldblum JR
    Mod Pathol; 2003 Apr; 16(4):316-24. PubMed ID: 12692197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Esophageal adenocarcinoma in a first-degree relative increases risk for esophageal adenocarcinoma in patients with Barrett's esophagus.
    Tofani CJ; Gandhi K; Spataro J; Yoo J; Murphy M; Mohan N; Daitch Z; Shah A; Janowski R; Huntley C; Dabbish N; Keith S; Coben R; Cohen S; Kastenberg D; Infantolino A
    United European Gastroenterol J; 2019 Mar; 7(2):225-229. PubMed ID: 31080607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide.
    Ghaus S; Neumann H; Muhammad H; Tontini GE; Ishaq S
    Dig Dis Sci; 2016 Aug; 61(8):2185-2193. PubMed ID: 27038446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosing Barrett's esophagus: reliability of clinical and pathologic diagnoses.
    Corley DA; Kubo A; DeBoer J; Rumore GJ
    Gastrointest Endosc; 2009 May; 69(6):1004-10. PubMed ID: 19152897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barrett's esophagus: a review.
    Sawyer DR; Longo WE; Naunheim KS
    Mo Med; 1995 Oct; 92(10):645-7. PubMed ID: 8559127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer Risk in Barrett's Esophagus: A Clinical Review.
    Beydoun AS; Stabenau KA; Altman KW; Johnston N
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance for Barrett's oesophagus. The conundrum of Barrett's oesophagus is changing.
    Eksteen JA; Jankowski JA
    BMJ; 2001 May; 322(7294):1124-5; author reply 1126. PubMed ID: 11360913
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial: discrepancies and pitfalls in diagnosis and therapy of esophageal columnar metaplasia/Barrett's esophagus: a personal view.
    Tytgat GN
    J Dig Dis; 2013 Aug; 14(8):405-8. PubMed ID: 23672505
    [No Abstract]   [Full Text] [Related]  

  • 39. DNA content in Barrett's esophagus and esophageal malignancy.
    McKinley MJ; Budman DR; Grueneberg D; Bronzo RL; Weissman GS; Kahn E
    Am J Gastroenterol; 1987 Oct; 82(10):1012-5. PubMed ID: 3661507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastro-esophageal reflux disease and Barrett's esophagus: an overview with an histologic diagnostic approach.
    Mastracci L; Grillo F; Parente P; Unti E; Battista S; Spaggiari P; Campora M; Scaglione G; Fassan M; Fiocca R
    Pathologica; 2020 Sep; 112(3):117-127. PubMed ID: 33179616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.